Payden Equity Income Fund Adviser Class PYVAX

Medalist Rating as of | See Payden Investment Hub
  • NAV / 1-Day Return 18.83  /  +0.75 %
  • Total Assets 1.1B
  • Adj. Expense Ratio
    1.010%
  • Expense Ratio 1.010%
  • Distribution Fee Level Above Average
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 5,000
  • Status Open
  • TTM Yield 0.94%
  • Turnover 112%

USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:50 AM GMT+0

Morningstar’s Analysis PYVAX

Will PYVAX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Payden Equity Income Adviser holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PYVAX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 29.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

4.92 55M
Technology

Amazon.com Inc

4.39 49M
Consumer Cyclical

Usd/Gbp Fwd 20260916 00049

3.72 42M
Derivative

JPMorgan Chase & Co

3.29 37M
Financial Services

Apple Inc

2.95 33M
Technology

Alphabet Inc Class A

2.90 32M
Communication Services

Morgan Stanley

2.71 30M
Financial Services

RTX Corp

2.16 24M
Industrials

Merck & Co Inc

2.16 24M
Healthcare

Cisco Systems Inc

2.08 23M
Technology

Sponsor Center